Sonacon

Sonacon Brand names, Sonacon Analogs

Sonacon Brand Names Mixture

No information avaliable

Sonacon Chemical_Formula

C₁₆H₁₃ClN₂O

Sonacon RX_link

http://www.rxlist.com/cgi/generic/diazepam.htm

Sonacon fda sheet

Sonacon msds (material safety sheet)

Sonacon MSDS

Sonacon Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Sonacon Molecular Weight

284.74 g/mol

Sonacon Melting Point

125-126^oC

Sonacon H₂O Solubility

Slightly soluble (50 mg/L)

Sonacon State

solid

Sonacon LogP

2.988

Sonacon Dosage Forms

Tablets; Injectable solution

Sonacon Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Sonacon Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Sonacon Absorption

Essentially complete, with a bioavailability of 93%.

Sonacon side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Sonacon Patient Information

Sonacon Organisms Affected

Humans and other mammals